medigraphic.com
Colegio de Medicina Interna de México.

2007, Number 4

<< Back Next >>

Med Int Mex 2007; 23 (4)

Epidermoid carcinoma of the bladder: atypical clinical manifestation

Cabello PLSA, Rojas DM, Sánchez MHF, Hernández CJC, Mora SV, Graef A, Landeros JI, Pérez DC

Language: Spanish
References: 16
Page: 355-358
PDF size: 297.82 Kb.


ABSTRACT

A case of epidermoid carcinoma of the bladder is reported in an 80 year-old masculine patient, with tabaquism antecedent since youth and clinical manifestation of abdominal pain in right lower quadrant of colic type, dysuria, vesical tenesmus and nicturia. Ultrasound results shows right hydronephrosis, and an intramural pediculated lesion in the floor of the bladder. Biopsy result was epidermoid carcinoma, very unusual.


REFERENCES

  1. Queipo Zaragoza JA, Chicote Perez F, Borell Palanca A, Beltran Meseguer JF, et al. Unusual bladder tumors: primary epidermoid carcinoma, adenocarcinoma, and sarcoma. Clinical behavior. Our experience. Actas Urol Esp 2003;27(2):123-31.

  2. Budia Alba A, Queipo Zaragoza JA, Perez Ebri ML, Fuster Escriva A, et al. Comparative study epidermoid carcinoma of the bladder and transitional cell carcinoma with squamous or mixed differentiated foci. Actas Urol Esp 1999;23(2):111-8.

  3. Shokeir AA. Squamous cell carcinoma of the bladder: pathology, diagnosis and treatment. BJU Int 2004;93(2):216-20.

  4. Desgrippes A, Meria P, Cortesse A, Cochand-Priolleet B, Cariou G. Epidermoid carcinoma of the bladder. Prog Urol 1998;8(3):321-9.

  5. El-Sebaie M, Zaghloul MS, Howard G, Mokhtar A. Squamous cell carcinoma of the bilharzial and no-bilharzial urinary bladder: a review of etiological features, natural history, and management. Int J Clin Oncol 2005;10(1):20-25.

  6. Debbagh A, Bennani S, Hafiani M, el Mrini M, Benjelloun S. Epidermoid carcinoma of the bladder. Apropos of 14 cases. Ann Urol 1997;31(4):199-203.

  7. Manunta A, Vincendeau S, Kiriakou G, Lobel B, Guillé F. Nontransitional cell bladder carcinomas. BJU Int 1995:497-502.

  8. Bussani R, Silvestri F, Giarelli L. Pure squamous cell and mixed transitional and squamous carcinoma of the bladder. A clinico-histophatological comparative study. Minerva Urol Nefrol 1989;41(3):177-81.

  9. Blaveri E, Simko JP, Korkola JE, Brewer JL, et al. Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Res 2005;11(11):4044-55.

  10. Badr KM, Nolen JD, Desore PB, Cohen C. Muscle invasive schistosomal squamous cell carcinoma of the urinary bladder: frequency and prognostic significance of p53, BCL-2, HER2/ neu and proliferation (MIB-1). Hum Pathol 2004;35(2):184-9.

  11. Swellam M, Abd-Elmaksoud N, Halim MH, Khatab H, Khiry H. Incidence of Bcl-2 expression in bladder cancer: relation to schistosomiasis. Clin Biochem 2004;37(9):798-802.

  12. Gee JR, Montoya RG, Khaled HM, Sabichi AL, Grossman HB. Cytokeratin 20, AN43, PGDH, and COX-2 expression in transitional and squamous cell carcinoma of the bladder. Urol Oncol 2003;21(4):266-70.

  13. Benson RC. Endoscopic management of bladder cancer with Hematoporphyrin derivative phototherapy. Urol Clin North Am 1984;120:637-16.

  14. Durdux C, Housset M. Facteurs pronostiques des tumeurs infiltrantes de vessie. Cancer Radiothér 1998;2(5):491-8.

  15. Cooke PW, James ND, Ganesan R, Burton A, et al. Bcl-2 expression identifies patients with advance bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapy. BJM Int 2000;85:829-35.

  16. Goffin JR, Rajan R, Souhami L. Tolerance of radiotherapy and chemotherapy in elderly patients with bladder cancer. Am J Clin Oncol 2004;27:172-7.




2020     |     www.medigraphic.com